| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.04 | 0.5 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.5 |